Mette Marianne Svenning is a Professor at the Department of Arctic and Marine Biology at UiT The Arctic University of Norway. Her research focuses on microbial communities in Arctic and high-latitude ecosystems, particularly methanotrophs and their roles in methane cycling, permafrost dynamics, and climate change feedbacks. She investigates microbial adaptations to extreme environments, including cold-adapted methanotrophs and their metabolic pathways. Her work integrates genomic, transcriptomic, and biogeochemical approaches to understand microbial contributions to global carbon cycles. Key research themes include methane oxidation mechanisms, microbial community responses to environmental changes, and symbiotic relationships in Arctic seep ecosystems. She has conducted extensive fieldwork in Svalbard and other Arctic regions, contributing to long-term ecological studies at Ny-Ålesund. Her research also explores applications in biotechnology, such as microbial consortia for methane conversion to industrial products. Dr. Svenning collaborates internationally on projects addressing permafrost thaw impacts, microbial biogeography, and the interplay between vegetation, herbivory, and soil microbiota. Her findings highlight the critical role of Arctic microorganisms in modulating greenhouse gas emissions under climate change scenarios.
جستوجوی استاد و پژوهشگر
استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشیتان را پیدا کنید و با او ارتباط بگیرید.
نمایش ۱۶-۳۰ از ۲۱۰ استاد راهنما
اطلاعات این پروفایلها از صفحات عمومی دانشگاهها جمعآوری شده و ممکن است بهروز نباشد.
Jan-Erik Berdal is an Associate Professor at the Faculty of Medicine, University of Oslo, affiliated with the Department of Microbiology and Infectious Diseases. His research focuses on infectious disease epidemiology, antibiotic resistance, and critical care microbiology, with extensive contributions to understanding hospital-acquired infections, sepsis, and SARS-CoV-2 dynamics. He collaborates with Akershus University Hospital and participates in multinational studies like ISARIC-COVID-19. Research interests include: Microbial pathogenesis in critical care settings Antibiotic therapy and resistance patterns Viral infections and immune responses (notably SARS-CoV-2) Development of diagnostic tools for infections Recent publications highlight his work on fecal microbiota transplantation for C. difficile , longitudinal transcriptomics in COVID-19, and biomarker utility in predicting outcomes. Studies span clinical trials, cohort analyses, and computational biology tools. Key collaborations include institutions across Norway and international networks (e.g., ISARIC). His work bridges clinical microbiology, public health, and data-driven diagnostics, emphasizing real-world applications in hospital settings.
Zhi Zhaoمشاهده پروفایل
پژوهشگر
Zhi Zhao is a Researcher at the University of Oslo's Faculty of Medicine, affiliated with the department of Statistical learning in molecular medicine. His work focuses on statistical and computational methods applied to molecular medicine, including omics data analysis, pharmacogenomics, and cancer genomics. Research Interests Statistical learning for multi-omics data integration Bayesian variable selection in drug sensitivity studies Biomarker discovery for immune-related diseases Survival analysis modeling in clinical applications Key Contributions Developed R packages like BayesSUR for multivariate Bayesian regression and EnrichIntersect for set enrichment analysis. His recent work includes studies on immune checkpoint inhibitor toxicity biomarkers and pan-cancer drug response prediction. Awards No scientific awards explicitly mentioned in the provided text. Labs/Teams Core member of the Statistical learning in molecular medicine research group.
- Molecular Biology
- Biochemistry
- Microbiology
- +۷ مورد دیگر
Trine Eker Christoffersen is the Acting Pro-Rector for Research and Director of Research at Østfold University College , holding strategic leadership roles from 2024 to 2025. She has a PhD in Biochemistry from the University of Oslo and holds higher degrees from Imperial College London and the University of Leeds. Education PhD, Biochemistry, University of Oslo (2007) MSc, Biochemical Research, Imperial College London (1999) BSc (Hons), Biotechnology, University of Leeds (1997) BSc, Chemical Engineering, Østfold University College (1995) Her research focuses on cell biology, microbiology, and immunology , particularly on bacteria-host interactions, probiotics, and intracellular signaling . She has contributed to understanding how non-commensal bacteria affect intestinal immunity and the functional diversity of growth factors. While her recent articles trend toward probiotic mechanisms, intestinal health, and cellular interactions , she also explores educational innovation and medical biochemistry . Her work includes collaborations with institutions like the University of Sydney and the University of Oslo. She leads initiatives in institutional research strategy and serves on committees like the Central PhD Committee and the Research Ethics Advisory Board.
Guro F. Giskeødegård is a Professor in Biostatistics at the Norwegian University of Science and Technology (NTNU), affiliated with the Department of Public Health and Nursing in the Faculty of Medicine and Health Sciences. She leads research at the HUNT Center for Molecular and Clinical Epidemiology, focusing on metabolomics and molecular -omics analysis of biological samples from patients and population biobanks. Her work emphasizes understanding disease mechanisms and identifying biomarkers for improved diagnosis and treatment, particularly in cancer (breast, ovarian, prostate) and metabolic disorders. Key areas include: Analysis of large-scale biological datasets Exercise-induced metabolic changes in human milk Cancer survivorship and sexual health outcomes Prostate cancer biobanking protocols Longitudinal metabolomics in breast cancer treatment Recent studies highlight her work on: Metformin’s immunomodulatory effects in PCOS pregnancies PET/MRI imaging in lymphoma diagnostics Spatial transcriptomics of prostate cancer microenvironments Machine learning applications in radiomics No specific scientific awards are listed in the provided data. Collaborations span multidisciplinary teams including statisticians, clinicians, and bioinformaticians. Her research integrates molecular epidemiology with clinical translation, emphasizing population health impacts.
- Systems Biology
- Metabolic Modeling
- NAD Metabolism
- +۷ مورد دیگر
Ines Heiland is a Professor at the Department of Biomedicine, Faculty of Medicine, University of Bergen. Her research integrates systems biology and computational modeling to investigate metabolic networks, with a focus on NAD and tryptophan metabolism, mitochondrial function, and circadian regulation. University: University of Bergen School: Faculty of Medicine Department: Department of Biomedicine Position: Professor Email: i.heiland@uib.no Her educational background is not explicitly detailed in the provided texts, but her extensive research and supervisory roles indicate a strong academic foundation in systems biology and molecular metabolism. Ines Heiland's research centers on understanding how metabolic networks regulate cellular health and disease. She employs computational models to study NAD homeostasis, tryptophan catabolism, and their roles in aging, cancer, and neurodegenerative conditions. Her work emphasizes the integration of multi-omics data and kinetic modeling to uncover regulatory mechanisms in metabolic pathways. The recent articles highlight a consistent focus on NAD metabolism, metabolic modeling, and the interplay between metabolism and epigenetics. Themes include the evolution of metabolic pathways, subcellular compartmentation of metabolites, and the development of bioinformatics tools for metabolic analysis. Her publications span from algorithm development (e.g., GEMCAT) to physiological insights in aging and disease. She has contributed to editorial and review work, such as the 2020 editorial on systems biology challenges and the 2015 review on NAD metabolism dynamics, underscoring her leadership in the field. Supervised PhD student: Mathias Bockwoldt Ines Heiland has been involved in collaborative research projects, often in partnership with institutions like UiT The Arctic University of Norway. She participates in networks such as NORBIS and BioCat, contributing to interdisciplinary efforts in biotechnology and systems biology. Her work involves both theoretical modeling and experimental validation, particularly in the context of marine biomass conversion and Arctic bioplastics.
Tom Luk R Michoel is a Professor at the Computational Biology Unit within the Department of Informatics at the University of Bergen. His research focuses on bioinformatics, computational biology, and machine learning applied to understanding gene regulation and causal relationships in biological systems. He teaches in both the Bachelor and Master programs in Informatics, including courses like BINF301 and MNF130. Research Interests: Michoel’s work explores how genetic variation influences gene expression and disease mechanisms. He develops machine learning algorithms to infer causal gene regulatory networks from large-scale genomic data, emphasizing causal inference over mere correlations. His recent projects include analyzing plasma protein networks linked to cardiovascular disease and applying Bayesian networks to understand gene-disease associations. Publications: His most recent work (2025) focuses on causal protein networks in myocardial infarction risk and network-driven frameworks for coronary artery disease studies. He also contributes to methodological advancements like integrating graph neural networks with metabolic models. Current Activities: Michoel leads the development of tools like Findr.jl for network inference and teaches short courses on causal inference in drug discovery. His lab collaborates on projects involving single-cell analysis, multi-tissue genomics, and systems pharmacology.
Marte Lie Høivik is a Professor at the University of Oslo's Institute of Clinical Medicine, Department of Gastroenterology and Hepatology. She serves as Senior Consultant and Head of the IBD Unit at Oslo University Hospital, leading the IBD research group and directing the IBSEN III study. Her research focuses on clinical and registry-based epidemiology in inflammatory bowel disease (IBD), with emphasis on clinical effectiveness, quality studies, prognostic research, and biomarker identification. Her work leverages large population-based cohorts like IBSEN to investigate disease course, treatment outcomes, and quality-of-life impacts. Recent publications reveal strong trends in risk prediction modeling, microbiome analysis, therapeutic drug monitoring, and real-world treatment effectiveness. Her team frequently examines understudied aspects like fatigue in remission, dietary impacts, and sex/gender differences in IBD outcomes using longitudinal cohort designs. Høivik actively supervises research within the IBSEN III cohort and collaborates extensively across Nordic countries on IBD epidemiology. Her team has published over 30 papers since 2021 in high-impact journals including Nature , Gastroenterology , and The Lancet Gastroenterology & Hepatology . She leads multiple research projects including the IBSEN III cohort study and NORDTREAT, with current funding supporting investigations into biomarkers, treatment strategies, and long-term disease outcomes in inflammatory bowel disease.
- Recirculating aquaculture systems (RAS)
- Fish welfare and ethology
- Water quality and ozonation
- +۳ مورد دیگر
Jelena Kolarevic is Professor at the Norwegian Fisheries College, UiT The Arctic University of Norway, Tromsø. She leads research on recirculating aquaculture systems (RAS), water-quality engineering, biosensor technology and salmon welfare, and participates in several national projects aimed at automating land-based salmon farming. Research interests revolve around the interface of technology and biology in closed-containment aquaculture. Her group develops real-time monitoring tools (acoustic, optical and biochemical sensors) to track fish behaviour, respiratory activity and water chemistry, with the overarching goal of optimising growth conditions and safeguarding welfare. Recent work explores how ozonation, photoperiod, CO₂ levels and soundscapes affect salmon performance and stress physiology. Across 60+ articles since 2020 she has advanced: (i) RAS water treatment (ozone, organic matter, disinfection by-products), (ii) sensor-based welfare indicators (accelerometers, ventilation loggers, passive acoustics), and (iii) physiological responses to fasting, salinity, CO₂ and oxidative disinfectants. These studies collectively underpin evidence-based protocols for large-scale, land-based salmon production. She currently heads or co-leads competitive grants including CandRAS (education for RAS industry), LAKSVEL (operational welfare indicators), Balanst (real-time control of fish-environment-energy) and multiple Nofima–UiT industry projects on ozonation, degassing and biosecurity. Professor Kolarevic is actively involved in supervising PhD and MSc candidates within the Aquaculture and Environment research group, although individual student names are not listed in the supplied text.
- Biostatistics
- Cancer Research
- Risk Prediction
- +۴ مورد دیگر
Manuela Karola Zucknick is a Professor in the Department of Biostatistics at the University of Oslo , where she leads statistical learning research for translational and clinical cancer applications. Her work focuses on integrating multi-omics data for personalized cancer therapies, predicting drug responses, and modeling prognosis. Director of Oslo Centre for Biostatistics and Epidemiology (2023–present) Professor (2022–present) and Associate Professor (2015–2022) at University of Oslo Research Interests span high-dimensional statistical modeling, Bayesian methods for heterogeneous data integration, regularization techniques, and applications in pharmacogenomics. She develops tools for drug combination screens, survival modeling, and risk prediction incorporating prior biological knowledge. Key domains: Biostatistics, Integrative Genomics, Precision Medicine Methodological focus: Bayesian structured variable selection, Penalized Regression Publications demonstrate expertise in pan-cancer transcriptomics, proteomics for pregnancy complications, and machine learning for DNA methylation analysis. Recent work includes Tutorial on Survival Modeling (2024) and Dose-Response Prediction (2023) applied to pharmacogenomic datasets. Collaborations span clinical trials in colorectal cancer nutrition, prostate cancer screening for Lynch syndrome patients, and chronic pain research using molecular profiling.
Natasa Nikolicمشاهده پروفایل
مدرس ارشد
Natasa Nikolic is a Senior Lecturer at the University of Oslo's Department of Pharmacy, affiliated with the Faculty of Mathematics and Natural Sciences. Her roles include teaching courses such as Pharmacotherapy 1, Pharmacotherapy 2 and Physiology 3, and Pharmaceutical Microbiology. She holds a PhD from the Department of Pharmacy (UiO) and has extensive postdoctoral research experience in pharmacology and metabolic studies. Education: Postdoc, Department of Pharmacy, University of Oslo PhD in Pharmacology, Department of Pharmacy, University of Oslo Cand.pharm (Pharmacy Degree), Department of Pharmacy, University of Oslo Research Interests: Metabolic adaptations in skeletal muscle cells In vitro modeling of exercise and metabolic disorders Role of electrical pulse stimulation in mimicking exercise effects Lipid and glucose metabolism in obesity and diabetes Her research emphasizes cellular models to study metabolic pathways, particularly how exercise mimetics and metabolic challenges affect skeletal muscle function. Key areas include mitochondrial function, substrate utilization, and disease modeling. Over 15 recent articles explore topics like fatty acid oxidation, oxidative capacity in spinal cord injury patients, and liver inflammation in NASH. Nikolic collaborates with institutions like the Norwegian Medicines Agency and European Medicines Agency. She has advised the Research Section at the Faculty of Mathematics and Natural Sciences and contributed to pharmaceutical research projects. Her lab's work focuses on translational pharmacology linking cellular metabolism to clinical outcomes.
Professor Hanne Cecilie Winther-Larsen works at the Department of Pharmacy , University of Oslo , focusing on Molecular Microbiology and Host-Pathogen Interactions in human and fish pathogens. Her research spans Vibrio cholerae, Francisella noatunensis, Piscirickettsia salmonis, and Yersinia ruckeri using zebrafish and mice models. Current projects include extracellular vesicles as fish vaccines Investigating antimicrobial resistance and microbiome impacts Collaborating with marine biotechnology and aquaculture industries Her work has been recognized with multiple University of Oslo publication prizes (2001, 2005, 2006, 2008). She teaches Pharmaceutical Microbiology and Molecular Microbiology in Oslo's 5-year pharmacy master's program. Recent publications demonstrate expertise in membrane vesicle engineering , cross-species vaccine development , and biofilm disruption using natural solvents. Research trends show strong emphasis on translating basic microbiology into applied aquaculture solutions while addressing global antimicrobial resistance challenges. Scientific awards include: 2001 Publication Prize, UiO 2005 Publication Prize, UiO 2006 Publication Prize, UiO 2008 Publication Prize, UiO She has led critical projects in Pharmaceutical Microbiology and Immunology , with extensive work on bacterial virulence factors and environmental microbiome interactions.
- Translation
- RNA biology
- Genome editing
- +۶ مورد دیگر
Eivind Valen is a Professor at the University of Oslo and holds multiple associate leadership roles at the Center for Molecular Medicine Norway (NCMM) , Center for Myeloid Blood Cancer (C-MYC) , Computational Biology Unit (CBU) , and Michael Sars Center . His research spans RNA biology, genome editing, and translation regulation. Research Focus: Investigates pervasive translation in non-coding regions, CRISPR applications, and RNA structure using nanopore sequencing. Key Tools: Developed CHOPCHOP platforms and ORFik for genome editing and translation analysis. Recent Article Trends: Emphasize ribosome profiling, poly(A) tail dynamics, and CRISPR precision. Awards: Includes ERC Consolidator Grant, EIC Pathfinder award, and KG Jebsen Center recognition. Collaborations: Engaged with institutions across Norway and Europe, including Technische Universität Dresden and EMBL nodes.
Kamran Shalchian-Tabrizi is a Professor at the Department of Biosciences, University of Oslo, affiliated with the Centre for Ecological and Evolutionary Synthesis. His research focuses on microbial biodiversity, evolution, and the interactions between microorganisms and their environments, with particular emphasis on soil health and sustainable agriculture. His research has evolved from investigating deep evolutionary relationships in protists to applied DNA-based ecology. He has made significant contributions to phylogenetic methods, DNA barcoding, and understanding major evolutionary transitions in life's history, including the origins of animals and plants from unicellular ancestors. His work on cellular organelle evolution, particularly chloroplasts through serial endosymbiosis, has provided insights into complex cellular structures. Shalchian-Tabrizi has developed advanced methods for high-resolution analysis of microbial communities using metagenomics, single-cell genomics, and transcriptomics. His current research focuses on soil health in agricultural systems, especially fruit production (apples, cherries, plums), where he leads several interdisciplinary projects including SICKSOIL and SOILHEALTH. These projects combine DNA sequencing with bioinformatics to address soil sickness and improve soil microbiota. He is also engaged in the innovative art-science collaboration 'Three Cells and Clay' with photographer Per Maning and architect Kristoffer Øyen, exploring the biological and symbolic relationship between humans and soil. This project represents his commitment to interdisciplinary approaches that bridge scientific understanding with artistic expression. Shalchian-Tabrizi actively collaborates with farmers, agricultural advisors, and public institutions, ensuring his research addresses real-world challenges in sustainable food production. His work demonstrates how scientific rigor combined with cross-sector collaboration can advance sustainable agricultural practices through microbiological insights.
Andrea Dalmao Fernansezمشاهده پروفایل
پژوهشگر ارشد
Andrea Dalmao Fernansez is a Postdoctoral Research Fellow at the University of Oslo, affiliated with the Krauss group Energy Metabolism in Health and Disease (MetHealth) . Her research focuses on skeletal muscle metabolism, mitochondrial dynamics, and inter-organ metabolic crosstalk, with significant contributions to understanding cellular adaptations in diseases like osteoarthritis and spinal cord injury. Institution: University of Oslo Research Group: Krauss group Energy Metabolism in Health and Disease (MetHealth) Email: a.d.fernandez@farmasi.uio.no Research Interests: Andrea investigates metabolic interactions between cell types in health and disease. Her work spans: Mitochondrial dysfunction in osteoarthritic cartilage Metabolic programming of skeletal muscle via krill oil supplementation Organ-on-chip models for islet-liver metabolic interactions Electrical stimulation effects on myotube metabolism Conditioned media signaling between bone and muscle cells Substrate utilization in human muscle cells Her recent publications highlight multi-omics approaches to study metabolic adaptations and 3D cell culture models for physiological studies.